Annan Yang
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
Papers in
-
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 3
- Oncology 9
- Pancreatic and Hepatic Oncology Research 4
- Cancer-related Molecular Pathways 2
- Co-authors
- Alec C. Kimmelman (4 shared papers)Xiaoxu Wang (3 shared papers)Kwok‐Kin Wong (3 shared papers)Nathanael S. Gray (5 shared papers)Daniel D. Von Hoff (1 shared paper)Brian M. Alexander (1 shared paper)Anirban Maitra (1 shared paper)N.V. Rajeshkumar (1 shared paper)
- Journals
- Cancer Discovery (3 papers)Cancer Research (3 papers)Nature Communications (1 paper)Journal of Medicinal Chemistry (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Annan Yang
16 papers receiving 2.1k citations
Annan Yang's Hit Papers
Peers
Comparison fields: 5 of 78
- Cancer Research 344
- Oncology 598
- Physiology 106
- Molecular Biology 1.4k
- Epidemiology 479
Countries citing papers authored by Annan Yang
This map shows the geographic impact of Annan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annan Yang more than expected).
Fields of papers citing papers by Annan Yang
This network shows the impact of papers produced by Annan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annan Yang. The network helps show where Annan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Annan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The dTAG system for immediate and target-specific protein degradation Hit paper breakdown → | 2018 | 682 |
| 2 | Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations Hit paper breakdown → | 2014 | 386 |
| 3 | 2019 | 257 | |
| 4 | 2018 | 241 | |
| 5 | 2018 | 178 | |
| 6 | 2008 | 117 | |
| 7 | 2014 | 81 | |
| 8 | 2023 | 47 | |
| 9 | 2011 | 29 | |
| 10 | 2020 | 29 | |
| 11 | 2019 | 26 | |
| 12 | 2023 | 10 | |
| 13 | 2016 | 6 | |
| 14 | 2025 | 3 | |
| 15 | 2022 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2023 | 0 | |
| 18 | 2022 | 0 | |
| 19 | 2024 | 0 |
About Annan Yang
Annan Yang is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Public Health, Environmental and Occupational Health, having authored 19 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (3 papers), Down syndrome and intellectual disability research (3 papers), Autophagy in Disease and Therapy (3 papers), Cancer-related Molecular Pathways (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Cancer Research (344 citations), Oncology (598 citations), Physiology (106 citations), Molecular Biology (1.4k citations) and Epidemiology (479 citations). Annan Yang has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Alec C. Kimmelman, Xiaoxu Wang, Kwok‐Kin Wong, Nathanael S. Gray, Daniel D. Von Hoff, Brian M. Alexander, Anirban Maitra, N.V. Rajeshkumar, Gerald C. Chu and Shinichi Yabuuchi. Their work appears in journals such as Cancer Discovery, Cancer Research, Nature Communications, Journal of Medicinal Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.